# A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

> **NCT02072993** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 116 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** AZD1979
- **DRUG:** Placebo to match

## Key facts

- **NCT ID:** NCT02072993
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 116 (ACTUAL)
- **Why stopped:** Study stopping criteria has been reached
- **Last updated:** 2014-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072993, "A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02072993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*